Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Diabetes

Free Subscription 02.02.2026 1 Acta Ophthalmol 1 Am Heart J 1 Am J Clin Nutr 1 Angiology 2 BMC Ophthalmol 1 BMC Pediatr 1 Circulation 6 Diabet Med 1 Diabetes 4 Diabetes Care 15 Diabetes Obes Metab 5 Diabetologia 1 J Am Coll Cardiol 1 J Clin Endocrinol Metab 1 J Diabetes Complications 2 J Hypertens 1 Kidney Int 2 Metabolism 1 Pediatr Diabetes 4 PLoS One 3 Proc Natl Acad Sci U S A 1 Stroke Vasc Interv Neurol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Ophthalmol

1. SKJOTH JB, Nielsen H, Orskov M, Cehofski L, et al
   Diabetic retinopathy in Greenland and Denmark-Can differences in risk factors explain the lower prevalence in Greenland?
   Acta Ophthalmol. 2026 Jan 28. doi: 10.1111/aos.70064.
   PubMed         Abstract available
   
   

   
   Am Heart J

2. CHANG LS, Hassan S, Chasse J, Stern G, et al
   Safety of a remote disease management program to improve sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists prescribing in type 2 diabetes with elevated cardiovascular or kidney risk.
   Am Heart J. 2026 Jan 27:107359. doi: 10.1016/j.ahj.2026.107359.
   PubMed         Abstract available
   
   

   
   Am J Clin Nutr

3. PETERSEN EE, Hansen JK, Torp N, Gram-Kampmann E, et al
   Health-related quality of life, compliance and sustained adherence on a Low-Carbohydrate High-Fat diet compared with a High-Carbohydrate Low-Fat diet in people with type 2 diabetes.
   Am J Clin Nutr. 2026 Jan 27:101211. doi: 10.1016/j.ajcnut.2026.101211.
   PubMed         Abstract available
   
   

   
   Angiology

4. DU X, Liu R, Guo D, Qiu Z, et al
   Predictive Value of Nutritional Scores for Contrast-Induced Acute Kidney Injury in Patients with Type 2 Diabetes Mellitus.
   Angiology. 2026 Jan 29:33197251399868. doi: 10.1177/00033197251399868.
   PubMed         Abstract available
   
   

   
   BMC Ophthalmol

5. HARLEY O, Amelia YS, Gustianty E, Soetedjo NNM, et al
   Resveratrol as a multitarget modulator in diabetic retinopathy: a systematic review of in vitro and in vivo studies.
   BMC Ophthalmol. 2026;26:55.
   PubMed         Abstract available
   
   
6. KHATHAMI AA, Baklola M, Alalyani MA, Aljuaid AT, et al
   Multimodal artificial intelligence in retinal vascular and neovascular macular diseases: a systematic review of diagnostic and prognostic applications.
   BMC Ophthalmol. 2025 Dec 24. doi: 10.1186/s12886-025-04561.
   PubMed         Abstract available
   
   

   
   BMC Pediatr

7. ILKHANIPOOR H, Taghadosi Far N, Moravej H, Barzegar H, et al
   Dyslipidemia in children with type 1 diabetes across age groups in Southern Iran: is it time to rethink guidelines?
   BMC Pediatr. 2026 Jan 26. doi: 10.1186/s12887-025-06504.
   PubMed         Abstract available
   
   

   
   Circulation

8. XU J, Wu Y, Song P, Zhang M, et al
   Retraction of: Proteasome-Dependent Degradation of Guanosine 5'-Triphosphate Cyclohydrolase I Causes Tetrahydrobiopterin Deficiency in Diabetes Mellitus.
   Circulation. 2026 Jan 30. doi: 10.1161/CIR.0000000000001420.
   PubMed        
   
   

   
   Diabet Med

9. CHI K, Liang Y, Li Y, Luo Z, et al
   Higher dietary magnesium intake and lower risks of all-cause, cardiovascular and kidney disease mortality in diabetes participants: A large cross-population cohort study.
   Diabet Med. 2026 Jan 23:e70223. doi: 10.1111/dme.70223.
   PubMed         Abstract available
   
   
10. BUDIANTO IR, Gosal E, Djuartina T, Sutrisno A, et al
    The association between Apolipoprotein A1, Apolipoprotein B and their ratio with diabetes-related neuropathy in elderly patients.
    Diabet Med. 2026 Jan 23:e70227. doi: 10.1111/dme.70227.
    PubMed         Abstract available
    
    
11. MECANI R, Muka T, Cigler M, Basta S, et al
    The use of diabetes technology under aviation conditions: A systematic review of human and in-vitro studies and future considerations.
    Diabet Med. 2026 Jan 23:e70220. doi: 10.1111/dme.70220.
    PubMed         Abstract available
    
    
12. MCCARTHY A, Thomas J, Avila E, Koutroukas V, et al
    Associations between impaired awareness of hypoglycaemia and mental health in insulin-treated type 2 and type 1 diabetes in the Hypo-METRICS study.
    Diabet Med. 2026 Jan 23:e70194. doi: 10.1111/dme.70194.
    PubMed         Abstract available
    
    
13. CARRIERI F, Scott EM, Murphy HR
    Invited commentary: Advancing the management of type 2 diabetes in pregnancy.
    Diabet Med. 2026 Jan 26:e70219. doi: 10.1111/dme.70219.
    PubMed        
    
    
14. KUNDU M, Funnell MP, Karimi Z, Kunutsor SK, et al
    Prognostic models for all-cause and cardiovascular mortality in type 2 diabetes: Systematic review.
    Diabet Med. 2026 Jan 28:e70218. doi: 10.1111/dme.70218.
    PubMed         Abstract available
    
    

    
    Diabetes

15. XIE C, White JB, Huang W, Horowitz M, et al
    Endogenous Glucagon-Like Peptide 1 Enhanced by Vildagliptin Reduces Triglyceride Appearance During Intraduodenal Fat Infusion in Type 2 Diabetes.
    Diabetes. 2026 Jan 27:db250980. doi: 10.2337/db25-0980.
    PubMed         Abstract available
    
    

    
    Diabetes Care

16. TEUFEL F, Orgutsova K, Genitsaridi I, Carrillo-Larco RM, et al
    Global, Regional, and National Estimates of Undiagnosed Diabetes in Adults: Findings From the 2025 IDF Diabetes Atlas.
    Diabetes Care. 2026 Jan 28:dc252583. doi: 10.2337/dc25-2583.
    PubMed         Abstract available
    
    
17. BAKHSH A, Saleemi A, Budhram D, Zhang Y, et al
    Chronic Kidney Disease and Risk of Diabetic Ketoacidosis in Type 1 Diabetes.
    Diabetes Care. 2026 Jan 27:dc251955. doi: 10.2337/dc25-1955.
    PubMed         Abstract available
    
    
18. LI HY, Chan TK, Co Shih K, Cheung BMY, et al
    GLP-1 Receptor Agonists and Risk of Optic Nerve or Vision-Threatening Events in Patients With Type 2 Diabetes or Cardiometabolic Diseases: A Meta-analysis of Randomized Controlled Trials.
    Diabetes Care. 2026 Jan 26:dc251929. doi: 10.2337/dc25-1929.
    PubMed         Abstract available
    
    
19. GISINGER T, He JH, Oyeka CP, Ma J, et al
    Sex Hormones and Cardiovascular Risk in Type 2 Diabetes: Cohort Study of the LookAHEAD Trial.
    Diabetes Care. 2026 Jan 26:dc252465. doi: 10.2337/dc25-2465.
    PubMed         Abstract available
    
    

    
    Diabetes Obes Metab

20. NARDONE M, Moedt E, Heerspink HJL, Davies MJ, et al
    Effects of sotagliflozin on markers of volume status and sodium handling in patients with type 1 diabetes: A biomarker analysis of the inTandem3 clinical trial.
    Diabetes Obes Metab. 2026 Jan 27. doi: 10.1111/dom.70520.
    PubMed         Abstract available
    
    
21. ZHU X, Lipscombe LL, Shulman R, Lovblom LE, et al
    Timing of insulin pump initiation among individuals with type 1 diabetes in Ontario, Canada.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70514.
    PubMed         Abstract available
    
    
22. GAO FM, Kishore K, Pandey D, Jahanabadi H, et al
    Effect of preoperative SGLT2 inhibitor use on postoperative acute kidney injury in patients with type 2 diabetes undergoing surgery: A causal inference study using routinely collected data.
    Diabetes Obes Metab. 2026 Jan 29. doi: 10.1111/dom.70509.
    PubMed         Abstract available
    
    
23. LEI L, Li Y, Chen S, Zou Y, et al
    Peptidylarginine deiminase 4-mediated neutrophil extracellular trap formation aggravates beta-cell damage in type 1 diabetes: A multi-model study.
    Diabetes Obes Metab. 2026 Jan 29. doi: 10.1111/dom.70442.
    PubMed         Abstract available
    
    
24. KEELS JN, LaPlante RD, Lee CS, Dwyer AA, et al
    Prevalence of new-onset diabetes following COVID-19 infection: A systematic review and meta-analysis.
    Diabetes Obes Metab. 2026 Jan 28. doi: 10.1111/dom.70508.
    PubMed         Abstract available
    
    
25. ABDEL-RAHMAN SM, Al-Shiab R, Shah E, Guldan M, et al
    Efficacy and safety of GLP-1 receptor agonists and SGLT2 inhibitors as adjuncts to insulin in type 1 diabetes: Systematic review and meta-analysis.
    Diabetes Obes Metab. 2026 Jan 28. doi: 10.1111/dom.70506.
    PubMed         Abstract available
    
    
26. PAVLOU P, Anandhakrishnan A, Athanasiadou KI, Brackenridge A, et al
    Discordant real-world glycaemic outcomes with Omnipod 5 and MiniMed 780G in adults with type 1 diabetes: Why validated measures matter.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70480.
    PubMed        
    
    
27. DICEMBRINI I, Poggi CD, Del Vescovo GG, Marinelli C, et al
    Efficacy of telemedicine on glycaemic control in nursing home residents with type 2 diabetes on basal-bolus insulin therapy: A randomised controlled trial.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70511.
    PubMed         Abstract available
    
    
28. 
    Correction to 'Early subcutaneous basal insulin with intravenous insulin infusion for diabetic ketoacidosis management: A systematic review and meta-analysis of randomised controlled trials'.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70518.
    PubMed        
    
    
29. GU Z, Chen L, Zhan K, Xi X, et al
    Development of the health economic model for type 2 diabetes considering glycaemic variability.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70451.
    PubMed         Abstract available
    
    
30. SUN M, Wang X, Lu Z, Yang Y, et al
    GLP-1RAs versus metformin and Parkinson's risk in type 2 diabetes.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70459.
    PubMed         Abstract available
    
    
31. MORRISSEY PI, Clarke ED, Loh XT, Collins CE, et al
    Nutrition interventions for anxiety, depression, stress and/or diabetes-related distress in individuals with diabetes: A systematic review and meta-analysis of randomised controlled trials.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70444.
    PubMed         Abstract available
    
    
32. MAKINO H, Kasahara M, Takashima R, Kasama S, et al
    Effect of empagliflozin on urinary albumin excretion and hypoxic biomarkers in early diabetic kidney disease: A randomised double-blind, placebo-controlled trial.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70485.
    PubMed         Abstract available
    
    
33. LI N, Sun J, Li H, Li C, et al
    Drug-gene interactions and the risk of diabetic microvascular complications: A population-based cohort study.
    Diabetes Obes Metab. 2026 Jan 26. doi: 10.1111/dom.70501.
    PubMed         Abstract available
    
    
34. BORLONGAN LAZ, Samante FLD, Ontingco AJM, Tilbe JPA, et al
    Impact of luseogliflozin on metabolic health, lipid profiles, and cardiovascular outcomes in patients with type II diabetes: A systematic review and network meta-analysis.
    Diabetes Obes Metab. 2026 Jan 25. doi: 10.1111/dom.70482.
    PubMed        
    
    

    
    Diabetologia

35. GITELMAN SE, Simmons K, Sherr JL, Quattrin T, et al
    Type 1 diabetes screening: reframing the debate from paternalism to partnership. Reply to Scaramuzza AE, Iafusco D, Cherubini V [letter] Type 1 diabetes screening: building a clinician-patient partnership for early care of chronic beta cell failure. R
    Diabetologia. 2026 Jan 24. doi: 10.1007/s00125-026-06673.
    PubMed        
    
    
36. SHARPE H, Lam GY
    The evolving understanding of cystic fibrosis-related diabetes in the highly effective modulator therapy era: a scoping review.
    Diabetologia. 2026 Jan 26. doi: 10.1007/s00125-025-06653.
    PubMed         Abstract available
    
    
37. BENTZEN JMM, Brask-Thomsen PK, Krogsbaek M, Hu X, et al
    Dermal fibroblast mitochondrial profiles in painful diabetic neuropathy.
    Diabetologia. 2026 Jan 26. doi: 10.1007/s00125-025-06660.
    PubMed         Abstract available
    
    
38. GIUDICELLI G, Krause N, Turin-Huet V, Robert M, et al
    Type 2 diabetes remission and metabolic outcomes 5 years after Roux-en-Y gastric bypass in young vs older adults: a multicentre matched cohort study.
    Diabetologia. 2026 Jan 29. doi: 10.1007/s00125-025-06665.
    PubMed         Abstract available
    
    
39. SIMO R, Hernandez C, Frontoni S, Sbraccia P, et al
    Relationship between retinal neurodysfunction and cognitive impairment in type 2 diabetes: results of the RECOGNISED cross-sectional study.
    Diabetologia. 2026 Jan 29. doi: 10.1007/s00125-025-06664.
    PubMed         Abstract available
    
    

    
    J Am Coll Cardiol

40. VERDECCHIA P, Angeli F, Reboldi G
    The Relation Between Blood Pressure and Outcomes in Diabetes: With or Without the J Curve?
    J Am Coll Cardiol. 2026 Jan 28:S0735-1097(25)10423.
    PubMed        
    
    

    
    J Clin Endocrinol Metab

41. RAMA CHANDRAN S, Koh Shimin J, Liu C, Xin Yu Lee I, et al
    Relationship between continuous glucose monitoring and corneal neuropathy in type 2 diabetes.
    J Clin Endocrinol Metab. 2026 Jan 28:dgag030. doi: 10.1210.
    PubMed         Abstract available
    
    

    
    J Diabetes Complications

42. LAN NSR, Fegan PG, Jenkins AJ
    High risk, low evidence: Need for more research on lipid-lowering therapies for people with type 1 diabetes.
    J Diabetes Complications. 2026;40:109268.
    PubMed        
    
    

    
    J Hypertens

43. WANG K, Kroon AA, de Galan BE, Berendschot TTJM, et al
    Associations of blood pressure with retinal arteriolar narrowing and urinary albumin excretion are modified by prediabetes: the Maastricht study.
    J Hypertens. 2026;44:461-469.
    PubMed         Abstract available
    
    
44. GILL E, Jin X, Fernandez C, Urbina EM, et al
    Association of hypertension disorders of pregnancy and left ventricular remodeling after 15 years follow-up: findings from the Bogalusa Heart Study.
    J Hypertens. 2025 Dec 18. doi: 10.1097/HJH.0000000000004216.
    PubMed         Abstract available
    
    

    
    Kidney Int

45. PATEL HA, Wang J, Zinn CJ, Learmonth M, et al
    Targeting Cellular Senescence in Diabetic Kidney Disease: Potential of Regenerative, Cell-based Therapies and Other Senotherapeutic Approaches.
    Kidney Int. 2026 Jan 23:S0085-2538(26)00054-2. doi: 10.1016/j.kint.2025.
    PubMed         Abstract available
    
    

    
    Metabolism

46. GIUSTINA A, di Filippo L, Aleksova A, Bollerslev J, et al
    Consensus statement on vitamin D role in metabolic health.
    Metabolism. 2026;176:156484.
    PubMed         Abstract available
    
    
47. LIN Z, Lv D, Zha H, Liu H, et al
    HMGCS2 desuccinylation modulates acetoacetate to drive tubule-macrophage inflammatory crosstalk in diabetic kidney disease.
    Metabolism. 2026;177:156510.
    PubMed         Abstract available
    
    

    
    Pediatr Diabetes

48. COHEN M, Weiss L, Weiss R, Shehadeh N, et al
    Apelin and Myostatin Levels in Adolescents With Type-1-Diabetes.
    Pediatr Diabetes. 2025;2025:1578938.
    PubMed         Abstract available
    
    

    
    PLoS One

49. JAYANTI RP, Cho YS, Soedarsono S, Kim HJ, et al
    Population pharmacokinetics model of pyrazinamide to optimize tuberculosis treatment: An interethnic cohort study of diabetes mellitus effect on drug exposure.
    PLoS One. 2026;21:e0340133.
    PubMed         Abstract available
    
    
50. LI Z, Chen X, Hu W, Li G, et al
    The relationship between METS-IR and the risk of diabetes incidence in rural adults in China: A retrospective cohort study based on dynamic population.
    PLoS One. 2026;21:e0341612.
    PubMed         Abstract available
    
    
51. DATTANI R, Ul-Haq Z, Shah M, Goldet G, et al
    Correction: Association and progression of multi-morbidity with Chronic Kidney Disease stage 3a secondary to Type 2 Diabetes Mellitus, grouped by albuminuria status in the multi-ethnic population of Northwest London: A real-world study.
    PLoS One. 2026;21:e0341903.
    PubMed         Abstract available
    
    
52. JARAB AS, Al-Qerem WA, Alqudah S, Alzoubi KH, et al
    Correction: Insulin-self administration among individuals with diabetes: Implications for improved practices.
    PLoS One. 2026;21:e0341749.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

53. SHIVANI ST, LeMasters BE, Ravula T, Esterly HJ, et al
    A structural model of toxic amyloid oligomers involved in type 2 diabetes.
    Proc Natl Acad Sci U S A. 2026;123:e2528103123.
    PubMed         Abstract available
    
    
54. LEMASTERS BE, Fields CR, Lomont JP, Chalyavi F, et al
    Mammals that can develop type 2 diabetes have a similarly structured beta-sheet amyloid oligomer.
    Proc Natl Acad Sci U S A. 2026;123:e2530570123.
    PubMed         Abstract available
    
    
55. WU S
    A neuron-astrocyte signaling axis in the ACC sustains diabetic neuropathic pain.
    Proc Natl Acad Sci U S A. 2026;123:e2533902123.
    PubMed        
    
    

    
    Stroke Vasc Interv Neurol

56. PERNG PS, Chang Y, Chuang MT, Wong CE, et al
    GLP-1 Receptor Agonists and Clinical Outcomes after Endovascular Treatment of Unruptured Aneurysms in Type 2 Diabetes.
    Stroke Vasc Interv Neurol. 2025;5:e001933.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Diabetes is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum